Menu

Pharmacovigilance

TASC has a centralised pharmacovigilance office based in the TASC R&D Office.  For More information on pharmacovigilance please refer to the TASC Pharmacovigilance Policy.

Serious Adverse Event Reporting
A ‘Serious Adverse Event and Adverse Reaction Report’ pro-forma (the detailed written report) is available for clinical trials for which TASC is acting as Pharmacovigilance sponsor.  In addition, Pregnancy Report Forms are available for clinical trials for which TASC is acting as Pharmacovigilance sponsor.

These forms should be completed and returned to:

Pharmacovigilance Section
Research Development Services
Level 3, Residency Block
Ninewells Hospital & Medical School

A copy should be sent as an email attachment to:

 pharmacovigilance.tayside@nhs.net

For further information and advice concerning serious adverse events and adverse reactions contact the TASC Research & Development Office on 01382 383886, extension from UoD phone 83886, NHS phone 77 83886.